| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nathalie Percie du Sert | Q43237313 |
| P2093 | author name string | Anthony M Holmes | |
| Rob Wallis | |||
| Paul Lr Andrews | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes | Q28208581 | ||
| Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 | ||
| The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D. | Q34107082 | ||
| Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
| Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets | Q34418906 | ||
| Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference | Q34562944 | ||
| Toxicology of Ipecac: A Review | Q36070464 | ||
| Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. | Q36429871 | ||
| American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. | Q36485520 | ||
| Principles of safety pharmacology | Q36801850 | ||
| Opportunities for the replacement of animals in the study of nausea and vomiting | Q37332618 | ||
| Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists | Q37761329 | ||
| The translational value of rodent gastrointestinal functions: a cautionary tale. | Q37870550 | ||
| A review of clinical trials of lithium in medicine | Q38583452 | ||
| Area postrema: chemoreceptor circumventricular organ of the medulla oblongata | Q38646128 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| Acute and chronic effects of lithium chloride on physiological and psychological measures in normals | Q39609753 | ||
| The pharmacology of (-)-nicotine and novel cholinergic channel modulators. | Q41188043 | ||
| Proposal for Pharmacologically Distinct Conformers of PDE4 Cyclic AMP Phosphodiesterases | Q41527389 | ||
| Time-course analysis of pica in rats using an automatic feeding monitoring system | Q43069546 | ||
| The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret | Q43280495 | ||
| Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study. | Q43538088 | ||
| Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret. | Q43596371 | ||
| Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. | Q43738036 | ||
| Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption ("pica") in rats | Q44199863 | ||
| Differential release of vasopressin and oxytocin in response to abdominal vagal afferent stimulation or apomorphine in the ferret | Q44494780 | ||
| The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feed | Q45982021 | ||
| Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets | Q46726791 | ||
| Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides | Q48120020 | ||
| Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio? | Q51674397 | ||
| Influence of the emetic reflex on vasopressin release in man | Q67004595 | ||
| Comparison of gastrointestinal responses to CCK-8 and associated with vomiting | Q68281808 | ||
| Antiemetic properties of the 5HT3-receptor antagonist, GR38032F | Q70047869 | ||
| A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides | Q73959330 | ||
| Emetic action of nicotine and lobeline | Q74750935 | ||
| Copper sulphate emesis; a study of afferent pathways from the gastrointestinal tract | Q75669479 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1848-1867 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Predicting the emetic liability of novel chemical entities: a comparative study | |
| P478 | volume | 165 |
| Q46743817 | 14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty |
| Q57161235 | A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research |
| Q46649469 | An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability |
| Q47158565 | Appropriateness to set a group health based guidance value for T2 and HT2 toxin and its modified forms |
| Q47159233 | Appropriateness to set a group health based guidance value for nivalenol and its modified forms |
| Q35159856 | Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration. |
| Q36509050 | Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol |
| Q46477578 | Comparison of three preclinical models for nausea and vomiting assessment |
| Q41949833 | Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret. |
| Q46240693 | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles |
| Q50433260 | Everyday memory: towards a translationally effective method of modelling the encoding, forgetting and enhancement of memory. |
| Q36769372 | Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). |
| Q64241539 | Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus |
| Q58721628 | Phosphodiesterase 4 inhibitor activates AMPK-SIRT6 pathway to prevent aging-related adipose deposition induced by metabolic disorder |
| Q28650531 | Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs) |
| Q35635673 | The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease |
| Q38209000 | The role of the parasympathetic nervous system in visually induced motion sickness: systematic review and meta-analysis |
| Q42594722 | Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment |
Search more.